510(k) Report

510(k) · Cleared

Cleared

Medgraphics Ultima System

K061731510(k) SpecialCleared Sep 6, 200678-day reviewClass II21 CFR 868.1730

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medical Graphics Corp. · BZL Computer, Oxygen-Uptake

Cleared on Sep 6, 2006 as substantially equivalent to K955432 (Medical Graphics Corp., 1996) after a 78-day review. Its family tree reaches back 1 generation to 1996. 6 later devices descend from it.

Decided
Sep 6, 2006
Review
78 days
Class
Class II
Product code
BZL
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K955432 (1996). 6 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2007: 2 descendants cleared2020: 2 descendants cleared2011: 1 descendant cleared2009: 1 descendant clearedK955432 · CPX, CCM, Cath with 15% CO2 · Medical Graphics Corp. · 19961995200020052010201520202025
Descendants, by generation 1 generation forward: 2 descendants2 generations forward: 4 descendants K955432 · CPX, CCM, Cath with 15% CO2 · Medical Graphics Corp. · 19960
  1. Root · 1 generation backK955432 CPX, CCM, Cath with 15% CO2Medical Graphics Corp. · 1996
  2. This deviceK061731 Medgraphics Ultima SystemMedical Graphics Corp. · 2006
  3. Descendant · cites it directly · 3 of its ownK071911 Cardiopulmonary Exercise Testing Option to InnocorInnovision A/S · 2007
  4. Descendant · 2 generations on · 2 of its ownK083879 Innocor Ergospirometry System (INN00010), the Basic Innocor…Innovision A/S · 2009
  5. Descendant · cites it directly · 2 of its ownK070858 Express SeriesMedical Graphics Corp. · 2007
  6. Descendant · 2 generations on · 0 of its ownK200076 Breezing MedTf Health Co. · 2020
  7. Descendant · 2 generations on · 0 of its ownK190561 NICU V'02Cosmed Nordic Aps · 2020

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2007: 22009: 12011: 12020: 2
2007high 2 (2007) · low 0 (2008)2026

Most influential descendants

Showing 5 of 6 · See all
  • K071911Cardiopulmonary Exercise Testing Option to InnocorInnovision A/S · 2007 · cites it directly3descendants
  • K083879Innocor Ergospirometry System (INN00010), the Basic Innocor Including Breath-by-Breath…Innovision A/S · 2009 · 2 generations on2descendants
  • K070858Express SeriesMedical Graphics Corp. · 2007 · cites it directly2descendants
  • K200076Breezing MedTf Health Co. · 2020 · 2 generations on0descendants
  • K190561NICU V'02Cosmed Nordic Aps · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K955432CPX, CCM, Cath with 15% CO2Medical Graphics Corp.1996—
0 (this device)K061731Medgraphics Ultima SystemMedical Graphics Corp.2006—
+1K071911Cardiopulmonary Exercise Testing Option to InnocorInnovision A/S2007—
+2K083879Innocor Ergospirometry System (INN00010), the Basic Innocor Including…Innovision A/S2009—
+1K070858Express SeriesMedical Graphics Corp.2007—
+2K200076Breezing MedTf Health Co.2020—
+2K190561NICU V'02Cosmed Nordic Aps2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200720
200910
201110
202020
FIG. 1 — Lineage of K061731, 1996–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in BZL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new BZL device

  1. #1 K190561 NICU V'02score 2.4 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K955432CPX, CCM, Cath with 15% CO2
Summary page 1
…Computer Device Class: Class Ila Predicate Device: Medgraphics Desktop Diagnostic System with 15% CO 2 Analyzer, K955432 manufactured by Medical Graphics Corporation, 350 Oak Grove Parkway, St. Paul, MN 55127. Description: The Ultima system…
Medical Graphics Corp.1996—

Also cleared against K955432: 1 other device →

What descends from it? (6)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K071911Cardiopulmonary Exercise Testing Option to InnocorInnovision A/S20073
K070858Express SeriesMedical Graphics Corp.20072

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K071911 (Innovision A/S, 2007) has gone furthest, with 3 descendants of its own.
  • 1 other device also cites its predicate K955432.

How does its category compare?

All BZL devices

BZL Computer, Oxygen-Uptake: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · BZL

2in 2020

2007: 22010: 12011: 12020: 2
2007high 2 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · BZL

Too few BZL 510(k)s in any year since 2007 to give a median.

Recalls per year · BZL

No recall names BZL since 2007.

Adverse event reports per year · BZL

1in 2023

2023: 1
2007high 1 (2023) · low 0 (2007)2025

MAUDE reports naming product code BZL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20080—00
20090—00
20101—00
20111—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20202—00
20210—00
20220—00
20230—01
20240—00
20250—00
20260—0—

What is it indicated for?

The Ultima system uses the direct measurement of oxygen uptake to objectively and non-invasively assess cardiac and pulmonary function during exercise. The system can be used to screen for early signs of cardiac and pulmonary dysfunction; differentiate heart and lung disease; assess dyspnea complaints; classify patients according to severity of disease as a guide for patient management; establish an optimal exercise prescription and training program…

Read the full statement (115 words)

The Ultima system uses the direct measurement of oxygen uptake to objectively and non-invasively assess cardiac and pulmonary function during exercise. The system can be used to screen for early signs of cardiac and pulmonary dysfunction; differentiate heart and lung disease; assess dyspnea complaints; classify patients according to severity of disease as a guide for patient management; establish an optimal exercise prescription and training program; evaluate the efficiency of prescribed therapy.

The Ultima system uses the direct measurement of oxygen uptake and carbon dioxide production to provide nutritional assessment, to optimize nutritional supplements and quantify substrate utilization.

The Ultima system can also provide direct Fick determination of cardiac output using real time oxygen uptake measurements.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K061731: Medgraphics Ultima System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K061731

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026